Biodesix, Inc. ( BDSX) - Stock Earnings
BDSX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 6, 2026, midnight | — / — | — | — / — | — |
BDSX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -8.7 million USD | 21.8 million USD |
| 2025Q4 | -4.0 million USD | 28.8 million USD |
| 2026Q1 | -7.8 million USD | 25.6 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
BDSX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -52.1 million USD | 49.1 million USD |
| 2024 | -42.9 million USD | 71.3 million USD |
| 2025 | -35.3 million USD | 88.5 million USD |
| 2026 Est. | — | — |
BDSX
Price: $19.90
52 week price:
Earnings Per Share: -3.96 USD
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 306900
Market Capitalization: 179.0 million